arrow
V

Venkatraman Radhakrishnan

University of California System
H指数:41
被引数:2.2万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The burden of childhood cancers in the South Asian Association for Regional Cooperation (SAARC) Region: a population-based, cross-sectional GLOBOCAN 2022 analysis

南亚区域合作联盟(SAARC)地区儿童癌症负担:一项基于人群的横断面GLOBOCAN 2022分析

2026-07-010
OAAI
Toxicity during induction of pulsed versus continuous prednisolone in children with acute lymphoblastic leukaemia: a multi-centre, open label, randomised, phase 3 trial from India (2016–2022)

脉冲与持续泼尼松诱导期间急性淋巴细胞白血病患者儿童的毒性比较:一项来自印度(2016–2022)的多中心、开放标签、随机、III期试验

2026-06-070
OAAI
Navigating the challenges in and identifying the priorities for childhood cancer survivorship in Asia

亚洲儿童癌症幸存者护理中的挑战与优先事项识别

2025-11-040
PRE
Neoadjuvant Chemotherapy with Trastuzumab with or without Concurrent Radiotherapy in HER2-Positive Inoperable Locally Advanced Breast Cancer: A Phase 2 Randomized Trial (NEOTRAC)

曲妥珠单抗联合或不联合同期放疗的新辅助化疗在HER2阳性不可手术局部晚期乳腺癌中的应用:一项II期随机试验(NEOTRAC)

2025-10-140
PRE
ASO Visual Abstract: Can Contralateral Template Dissection Be Avoided in Post-chemotherapy Retroperitoneal Lymph Node Dissection for Non-seminomatous Germ Cell Tumors?

ASO可视化摘要:化疗后腹膜后淋巴结清扫术治疗非精原细胞瘤性生殖细胞肿瘤时,能否避免对侧模板解剖?

2025-08-270
PRE
Correction: Can Contralateral Template Dissection be Avoided in Post-chemotherapy Retroperitoneal Lymph Node Dissection for Non-seminomatous Germ Cell Tumors?

更正:在非精原细胞瘤性生殖细胞肿瘤的化疗后腹膜后淋巴结清扫术中,能否避免对侧模板切除?

2025-08-160
PRE
Dexamethasone for 12 weeks for reducing fatigue in patients receiving palliative chemotherapy: A Phase 3, Placebo-Controlled, Randomized Controlled Trial

地塞米松治疗12周以减轻接受姑息化疗患者的疲劳:一项III期、安慰剂对照、随机对照试验

2025-07-310
PRE
Global burden of vision impairment due to age-related macular degeneration, 1990–2021, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2021

1990—2021年与年龄相关性黄斑变性相关的视力损害全球负担,以及至2050年的预测:一项针对2021年全球疾病负担研究的系统分析

2025-06-250
OA
Risk stratified treatment for childhood acute lymphoblastic leukaemia: a multicentre observational study from India

儿童急性淋巴细胞白血病的风险分层治疗:一项来自印度的多中心观察性研究

2025-06-010
PRE
Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021

1990至2021 204个国家和地区以及811个地方的371疾病和伤害的全球发病率,患病率,残疾寿命 (YLDs),残疾调整寿命 (DALYs) 和健康预期寿命 (HALE): 全球疾病负担研究2021的系统分析

LANCET
IF88.5
2024-05-01285
OAAI
Global fertility in 204 countries and territories, 1950-2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021

1950至2021 204个国家和地区的全球生育率,预测到2100: 全球疾病负担研究2021的综合人口分析

LANCET
IF88.5
2024-05-0143
OAAI
Burden of disease scenarios for 204 countries and territories, 2022-2050: a forecasting analysis for the Global Burden of Disease Study 2021

2022至2050 204个国家和地区的疾病负担情景: 全球疾病负担研究2021的预测分析

LANCET
IF88.5
2024-05-0179
OAAI
Temporal patterns of cancer burden in Asia, 1990-2019: a systematic examination for the Global Burden of Disease 2019 study

1990至2019亚洲癌症负担的时间模式: 全球疾病负担2019研究的系统检查

2024-02-018
OAAI
An assessment of childhood cancer care services in India - gaps, challenges and the way forward
2023-09-013
OAAI